<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01923961</url>
  </required_header>
  <id_info>
    <org_study_id>KSSA0113</org_study_id>
    <nct_id>NCT01923961</nct_id>
  </id_info>
  <brief_title>Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration</brief_title>
  <official_title>Impact of an Increased Sodium Chloride Concentration in the Infusion Fluid of Predilution Hemodiafiltration on the Removal of Protein-Bound Uremic Toxins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EXcorLab GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EXcorLab GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An increase of the free fraction may allow a better removal of of protein-bound uremic toxins
      during dialysis. During predilution hemodiafiltration, the sodium chloride (NaCl)
      concentration will be increased in the infusion fluid at a target NaCl concentration and the
      effect on the removal of protein-bound toxins will be determined. Comparisons will be made to
      standard hemodialysis and hemodiafiltration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eight maintenance dialysis patients will be enrolled in a prospective, randomized, crossover
      trial. HD will be compared with online pre-dilution HDF and HDF at increased plasma ionic
      strength. The ionic strength will be increased using an infusion fluid with hypertonic [Na+]
      by isovolumetric adding of a 5000 mmol/L NaCl solution. Blood and dialysate flowrates (250
      and 575 mL/min, respectively), treatment time (240 min), and high-flux dialyser (surface area
      2.1 sqm, PUREMA H) will be always kept identical. Anticoagulation with standard or
      fractionated heparin will be unchanged adopted from the patients' routinely used regimen. In
      both HDF modes, the infusion flow rate will be 125 mL/min. In HDF at increased plasma ionic
      strength, the infusate [Na+] will be adjusted to approach 240 mmol/L in plasma entering the
      dialyser and the dialysate [Na+] will be set at the technically feasible minimum of 130
      mmol/L. Blood samples will be drawn from the arterial and venous blood lines and, if
      applicable, from the blood tubing connecting the two dialyzers at 0, 15, 30, 60, 120, 180,
      and 240 min. Samples at 240 min will be drawn after reducing the blood flow rate to 50 mL/min
      for 30 s and the dialysate flow turned off. A fraction of the spent dialysate will be
      continuously collected.

      Removal of the free and total fraction of para-cresyl sulfate and indoxyl sulfate will be
      determined by reduction ratios, dialytic clearances and mass in dialysate

      Hemocompatibility will be assessed by WBC and platelet counts, free Hb, LDH, C5a and TAT.
      [Na+] will be monitored in both arterial (i.e. before NaCl infusion) and venous blood of the
      extracorporeal system.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">August 10, 2015</completion_date>
  <primary_completion_date type="Actual">March 30, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Removal of Para-cresylsulfate</measure>
    <time_frame>4 hours</time_frame>
    <description>Determination of reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Removal of Indoxylsulfate</measure>
    <time_frame>4 hours</time_frame>
    <description>Determination of the reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Sodium Concentrations</measure>
    <time_frame>4 hours</time_frame>
    <description>Maximum arterial sodium concentrations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemocompatibility</measure>
    <time_frame>4 hours</time_frame>
    <description>Maximum free hemoglobin in plasma, which indicates hemolysis. Hemoglobin is released into plasma in case of red blood cell destruction.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">8</enrollment>
  <condition>End-stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>HDF NaCl, Then HD, Then Standard Pre-HDF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants first receive hemodiafiltration with infusion of 5 M NaCl for 4 hours. After a washout period of 1 week, they then receive 4 hours of bicarbonate hemodialysis. After another washout period of 1 week, they reveive 4 hours of standard predilution hemodiafiltration.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HD, Then Standard Pre-HDF, Then HDF NaCl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants first receive bicarbonate hemodialysis for 4 hours. After a washout period of 1 week, they then receive 4 hours of standard predilution hemodiafiltration. After another washout period of 1 week, they reveive 4 hours of hemodiafiltration with infusion of 5 M NaCl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Pre-HDF, Then HDF NaCl, Then HD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants first receive standard predilution hemodiafiltration for 4 hours. After a washout period of 1 week, they then receive hemodiafiltration with infusion of 5 M NaCl 4 hours of. After another washout period of 1 week, they reveive 4 hours of bicarbonate hemodialysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HDF NaCl</intervention_name>
    <arm_group_label>HD, Then Standard Pre-HDF, Then HDF NaCl</arm_group_label>
    <arm_group_label>HDF NaCl, Then HD, Then Standard Pre-HDF</arm_group_label>
    <arm_group_label>Standard Pre-HDF, Then HDF NaCl, Then HD</arm_group_label>
    <other_name>Hemodialysis</other_name>
    <other_name>Standard Predilution Hemodiafiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemodialysis</intervention_name>
    <arm_group_label>HD, Then Standard Pre-HDF, Then HDF NaCl</arm_group_label>
    <arm_group_label>HDF NaCl, Then HD, Then Standard Pre-HDF</arm_group_label>
    <arm_group_label>Standard Pre-HDF, Then HDF NaCl, Then HD</arm_group_label>
    <other_name>Standard Predilution Hemodiafiltration</other_name>
    <other_name>HDF NaCl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Predilution Hemodiafiltration</intervention_name>
    <arm_group_label>HD, Then Standard Pre-HDF, Then HDF NaCl</arm_group_label>
    <arm_group_label>HDF NaCl, Then HD, Then Standard Pre-HDF</arm_group_label>
    <arm_group_label>Standard Pre-HDF, Then HDF NaCl, Then HD</arm_group_label>
    <other_name>HDF NaCl</other_name>
    <other_name>Hemodialysis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  End-stage renal disease

          -  Maintenance hemodialysis or hemodiafiltration for more than 3 months

          -  Stable clinical condition

          -  &gt; 18 years

        Exclusion Criteria:

          -  Life expectancy less than 1 year

          -  Pregnancy

          -  Active infectious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Detlef H Krieter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuerzburg University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dialysis Center Elsenfeld</name>
      <address>
        <city>Elsenfeld</city>
        <state>Bavaria</state>
        <zip>63820</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>August 10, 2013</study_first_submitted>
  <study_first_submitted_qc>August 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2013</study_first_posted>
  <results_first_submitted>July 30, 2017</results_first_submitted>
  <results_first_submitted_qc>July 27, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 16, 2019</results_first_posted>
  <last_update_submitted>July 27, 2018</last_update_submitted>
  <last_update_submitted_qc>July 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Maintenance hemodialysis or hemodiafiltration</keyword>
  <keyword>&gt;18 years</keyword>
  <keyword>Stable condition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HDF NaCl Infusion, Then HD, Then Standard Pre-HDF</title>
          <description>Participants first received hemodiafiltration with infusion of 5 M NaCl for 4 hours. After a washout period of 1 week, they then received 4 hours of bicarbonate hemodialysis. After another washout period of 1 week, they reveived 4 hours of standard predilution hemodiafiltration.</description>
        </group>
        <group group_id="P2">
          <title>HD, Then Standard Pre-HDF, Then HDF NaCl Infusion</title>
          <description>Participants first received bicarbonate hemodialysis for 4 hours. After a washout period of 1 week, they then received 4 hours of standard predilution hemodiafiltration. After another washout period of 1 week, they reveived 4 hours of hemodiafiltration with infusion of 5 M NaCl.</description>
        </group>
        <group group_id="P3">
          <title>Standard Pre-HDF, Then HDF NaCl Infusion, Then HD</title>
          <description>Participants first received standard predilution hemodiafiltration for 4 hours. After a washout period of 1 week, they then received 4 hours of hemodiafiltration with infusion of 5 M NaCl. After another washout period of 1 week, they reveived 4 hours of bicarbonate hemodialysis.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (1 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HDF NaCl, Then HD, Then Standard Pre-HDF</title>
          <description>Participants first received hemodiafiltration with infusion of 5 M NaCl for 4 hours. After a washout period of 1 week, they then received 4 hours of bicarbonate hemodialysis. After another washout period of 1 week, they reveived 4 hours of standard predilution hemodiafiltration.</description>
        </group>
        <group group_id="B2">
          <title>HD, Then Standard Pre-HDF, Then HDF NaCl</title>
          <description>Participants first received bicarbonate hemodialysis for 4 hours. After a washout period of 1 week, they then received 4 hours of standard predilution hemodiafiltration. After another washout period of 1 week, they reveived 4 hours of hemodiafiltration with infusion of 5 M NaCl.</description>
        </group>
        <group group_id="B3">
          <title>Standard Pre-HDF, Then HDF NaCl, Then HD</title>
          <description>Participants first received standard predilution hemodiafiltration for 4 hours. After a washout period of 1 week, they then received 4 hours of hemodiafiltration with infusion of 5 M NaCl. After another washout period of 1 week, they reveived 4 hours of bicarbonate hemodialysis.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="2"/>
            <count group_id="B4" value="8"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="46" upper_limit="78"/>
                    <measurement group_id="B2" value="62" lower_limit="46" upper_limit="78"/>
                    <measurement group_id="B3" value="62" lower_limit="46" upper_limit="78"/>
                    <measurement group_id="B4" value="62" lower_limit="46" upper_limit="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sodium Chloride (NaCl) Infusion</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Removal of Para-cresylsulfate</title>
        <description>Determination of reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
        <time_frame>4 hours</time_frame>
        <population>Per protocol population</population>
        <group_list>
          <group group_id="O1">
            <title>Hemodiafiltration, NaCl Infusion</title>
            <description>5 M NaCl solution will be infused to increase the NaCl concentration in the infusion fluid during predilution hemodiafiltration.
5 M NaCl solution: Infusion of 5 M NaCl adjusted at target NaCl concentration in plasma.</description>
          </group>
          <group group_id="O2">
            <title>Hemodialysis</title>
            <description>Standard bicarbonate high-flux hemodialysis</description>
          </group>
          <group group_id="O3">
            <title>Hemodiafiltration</title>
            <description>Standard predilution Hemodiafiltration</description>
          </group>
        </group_list>
        <measure>
          <title>Removal of Para-cresylsulfate</title>
          <description>Determination of reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
          <population>Per protocol population</population>
          <units>percentage of reduction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.0" spread="22.1"/>
                    <measurement group_id="O2" value="32.6" spread="18.5"/>
                    <measurement group_id="O3" value="33.6" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Removal of Indoxylsulfate</title>
        <description>Determination of the reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
        <time_frame>4 hours</time_frame>
        <population>Per protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Hemodiafiltration, NaCl Infusion</title>
            <description>5 M NaCl solution will be infused to increase the NaCl concentration in the infusion fluid during predilution hemodiafiltration.
5 M NaCl solution: Infusion of 5 M NaCl adjusted at target NaCl concentration in plasma.</description>
          </group>
          <group group_id="O2">
            <title>Hemodialysis</title>
            <description>Standard bicarbonate high-flux hemodialysis</description>
          </group>
          <group group_id="O3">
            <title>Hemodiafiltration</title>
            <description>Standard predilution Hemodiafiltration</description>
          </group>
        </group_list>
        <measure>
          <title>Removal of Indoxylsulfate</title>
          <description>Determination of the reduction ratio, which is the ratio of a solute concentration in plasma at baseline and at the end of the intervention</description>
          <population>Per protocol analysis</population>
          <units>percentage of reduction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.8" spread="23.5"/>
                    <measurement group_id="O2" value="26.5" spread="18.1"/>
                    <measurement group_id="O3" value="30.9" spread="23.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Sodium Concentrations</title>
        <description>Maximum arterial sodium concentrations</description>
        <time_frame>4 hours</time_frame>
        <population>Per protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Hemodiafiltration, NaCl Infusion</title>
            <description>5 M NaCl solution will be infused to increase the NaCl concentration in the infusion fluid during predilution hemodiafiltration.
5 M NaCl solution: Infusion of 5 M NaCl adjusted at target NaCl concentration in plasma.</description>
          </group>
          <group group_id="O2">
            <title>Hemodialysis</title>
            <description>Standard bicarbonate high-flux hemodialysis</description>
          </group>
          <group group_id="O3">
            <title>Hemodiafiltration</title>
            <description>Standard predilution Hemodiafiltration</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Sodium Concentrations</title>
          <description>Maximum arterial sodium concentrations</description>
          <population>Per protocol analysis</population>
          <units>mval/l</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="136" spread="3"/>
                    <measurement group_id="O2" value="133" spread="2"/>
                    <measurement group_id="O3" value="134" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemocompatibility</title>
        <description>Maximum free hemoglobin in plasma, which indicates hemolysis. Hemoglobin is released into plasma in case of red blood cell destruction.</description>
        <time_frame>4 hours</time_frame>
        <population>Per protocol analysis</population>
        <group_list>
          <group group_id="O1">
            <title>Hemodiafiltration, NaCl Infusion</title>
            <description>5 M NaCl solution will be infused to increase the NaCl concentration in the infusion fluid during predilution hemodiafiltration.
5 M NaCl solution: Infusion of 5 M NaCl adjusted at target NaCl concentration in plasma.</description>
          </group>
          <group group_id="O2">
            <title>Hemodialysis</title>
            <description>Standard bicarbonate high-flux hemodialysis</description>
          </group>
          <group group_id="O3">
            <title>Hemodiafiltration</title>
            <description>Standard predilution Hemodiafiltration</description>
          </group>
        </group_list>
        <measure>
          <title>Hemocompatibility</title>
          <description>Maximum free hemoglobin in plasma, which indicates hemolysis. Hemoglobin is released into plasma in case of red blood cell destruction.</description>
          <population>Per protocol analysis</population>
          <units>percentage of total hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.09" spread="0.04"/>
                    <measurement group_id="O2" value="0.07" spread="0.03"/>
                    <measurement group_id="O3" value="0.08" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Hemodiafiltration, NaCl Infusion</title>
          <description>5 M NaCl solution will be infused to increase the NaCl concentration in the infusion fluid during predilution hemodiafiltration.
5 M NaCl solution: Infusion of 5 M NaCl adjusted at target NaCl concentration in plasma.</description>
        </group>
        <group group_id="E2">
          <title>Hemodialysis</title>
          <description>Standard bicarbonate high-flux hemodialysis</description>
        </group>
        <group group_id="E3">
          <title>Hemodiafiltration</title>
          <description>Standard predilution Hemodiafiltration</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>`Dr. Horst-Dieter Lemke</name_or_title>
      <organization>eXcorLab GmbH</organization>
      <phone>+49-6022-812647</phone>
      <email>horstdieter.lemke@excorlab.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

